Brian Verrier

Chief Executive Officer Mr. Verrier has spent the last 28 years in medtech, most recently serving as the President of Covidien/Medtronic $1.2B Peripheral Vascular Business. During Brian’s tenure at Covidien the Peripheral Vascular grew from $350M to $1.2B through a series of acquisitions and a focused organic portfolio development strategy. Prior to Covidien Brian spent…

Brian Verrier

Chief Executive Officer Mr. Verrier has spent the last 28 years in medtech, most recently serving as the President of Covidien/Medtronic $1.2B Peripheral Vascular Business. During Brian’s tenure at Covidien the Peripheral Vascular grew from $350M to $1.2B through a series of acquisitions and a focused organic portfolio development strategy. Prior to Covidien Brian spent…

Brian Verrier

Chief Executive Officer Mr. Verrier has spent the last 28 years in medtech, most recently serving as the President of Covidien/Medtronic $1.2B Peripheral Vascular Business. During Brian’s tenure at Covidien the Peripheral Vascular grew from $350M to $1.2B through a series of acquisitions and a focused organic portfolio development strategy. Prior to Covidien Brian spent…

Brian Verrier

Chief Executive Officer Mr. Verrier has spent the last 28 years in medtech, most recently serving as the President of Covidien/Medtronic $1.2B Peripheral Vascular Business. During Brian’s tenure at Covidien the Peripheral Vascular grew from $350M to $1.2B through a series of acquisitions and a focused organic portfolio development strategy. Prior to Covidien Brian spent…